Ghavami S - Search Results

1

Progress in Precision Medicine for Head and Neck Cancer.

Vakili S, Behrooz AB, Whichelo R, Fernandes A, Emwas AH, Jaremko M, Markowski J, Los MJ, Ghavami S, Vitorino R. Vakili S, et al. Among authors: ghavami s. Cancers (Basel). 2024 Nov 4;16(21):3716. doi: 10.3390/cancers16213716. Cancers (Basel). 2024. PMID: 39518152 Free PMC article. Review.

2

Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.

Barczyk K, Kreuter M, Pryjma J, Booy EP, Maddika S, Ghavami S, Berdel WE, Roth J, Los M. Barczyk K, et al. Among authors: ghavami s. Int J Cancer. 2005 Aug 20;116(2):167-73. doi: 10.1002/ijc.21037. Int J Cancer. 2005. PMID: 15800951

3

Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.

Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M. Maddika S, et al. Among authors: ghavami s. J Cell Sci. 2005 Oct 1;118(Pt 19):4485-93. doi: 10.1242/jcs.02580. J Cell Sci. 2005. PMID: 16179607 Free article.

4

Apoptosis in liver diseases--detection and therapeutic applications.

Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Ghavami S, et al. Med Sci Monit. 2005 Nov;11(11):RA337-45. Med Sci Monit. 2005. PMID: 16258409 Free article. Review.

5

S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.

Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T, Los M. Ghavami S, et al. Biochim Biophys Acta. 2008 Feb;1783(2):297-311. doi: 10.1016/j.bbamcr.2007.10.015. Epub 2007 Nov 7. Biochim Biophys Acta. 2008. PMID: 18060880 Free article.

6

Autoimmunity and apoptosis--therapeutic implications.

Rashedi I, Panigrahi S, Ezzati P, Ghavami S, Los M. Rashedi I, et al. Among authors: ghavami s. Curr Med Chem. 2007;14(29):3139-51. doi: 10.2174/092986707782793952. Curr Med Chem. 2007. PMID: 18220747 Review.

7

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.

Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. Ghavami S, et al. J Leukoc Biol. 2008 Jun;83(6):1484-92. doi: 10.1189/jlb.0607397. Epub 2008 Mar 13. J Leukoc Biol. 2008. PMID: 18339893 Free PMC article.

8

Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway.

Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M. Ghavami S, et al. J Cell Mol Med. 2008 Jun;12(3):1005-22. doi: 10.1111/j.1582-4934.2008.00129.x. J Cell Mol Med. 2008. PMID: 18494941 Free PMC article.

9

Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression.

Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH, Wesselborg S, Halayko AJ, Klonisch T, Los M. Ghavami S, et al. Biochim Biophys Acta. 2009 Mar;1793(3):546-60. doi: 10.1016/j.bbamcr.2009.01.002. Epub 2009 Jan 15. Biochim Biophys Acta. 2009. PMID: 19321129 Free article.

10

S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.

Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C, Los M. Ghavami S, et al. Cell Res. 2010 Mar;20(3):314-31. doi: 10.1038/cr.2009.129. Epub 2009 Nov 24. Cell Res. 2010. PMID: 19935772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters